Alnylam Pharmaceuticals
Klaus Charisse currently holds various high-level positions at Alnylam Pharmaceuticals, where they have been working since 2003. They are responsible for bionanalytical and quality control, stability, metabolism, RNA synthesis, and research analytics. Prior to joining Alnylam, they worked as a Manager at MWG Biotech. Klaus obtained a Ph.D. in Chemistry from Universitaet Tuebingen in 1999.
This person is not in any teams
Alnylam Pharmaceuticals
32 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.